National Pension Service Has $41.77 Million Stock Holdings in STERIS plc $STE

National Pension Service raised its holdings in STERIS plc (NYSE:STE) by 1.8% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 168,802 shares of the medical equipment provider’s stock after acquiring an additional 3,044 shares during the quarter. National Pension Service owned approximately 0.17% of STERIS worth $41,768,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the business. Steigerwald Gordon & Koch Inc. bought a new stake in shares of STERIS in the third quarter worth $25,000. Spurstone Advisory Services LLC bought a new position in STERIS during the 2nd quarter worth $29,000. Cloud Capital Management LLC acquired a new position in STERIS during the 3rd quarter worth about $29,000. Geneos Wealth Management Inc. grew its position in shares of STERIS by 416.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 104 shares during the last quarter. Finally, TruNorth Capital Management LLC acquired a new stake in shares of STERIS in the third quarter valued at about $37,000. Institutional investors own 94.69% of the company’s stock.

Insider Transactions at STERIS

In other news, VP Julia Madsen sold 5,008 shares of STERIS stock in a transaction on Friday, November 21st. The shares were sold at an average price of $262.00, for a total value of $1,312,096.00. Following the completion of the sale, the vice president owned 10,710 shares in the company, valued at $2,806,020. The trade was a 31.86% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, VP Renato Tamaro sold 5,036 shares of the business’s stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $257.55, for a total transaction of $1,297,021.80. Following the transaction, the vice president owned 5,695 shares in the company, valued at $1,466,747.25. The trade was a 46.93% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 25,044 shares of company stock valued at $6,586,218 in the last quarter. 1.07% of the stock is currently owned by company insiders.

STERIS Stock Performance

Shares of STERIS stock opened at $264.85 on Tuesday. The company has a current ratio of 2.37, a quick ratio of 1.63 and a debt-to-equity ratio of 0.27. The business has a 50-day moving average price of $259.33 and a two-hundred day moving average price of $249.18. STERIS plc has a 1-year low of $204.90 and a 1-year high of $269.44. The company has a market cap of $25.99 billion, a P/E ratio of 38.05 and a beta of 1.03.

STERIS (NYSE:STE) last announced its quarterly earnings data on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.38 by $0.09. STERIS had a return on equity of 14.43% and a net margin of 12.07%.The company had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same period in the previous year, the business earned $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. As a group, analysts anticipate that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Tuesday, February 17th will be issued a dividend of $0.63 per share. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Tuesday, February 17th. STERIS’s dividend payout ratio is presently 36.21%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a research note on Friday, January 9th. Six investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, STERIS presently has a consensus rating of “Moderate Buy” and an average target price of $275.20.

STERIS Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.